L’Occitane Groupe, the celebrated skincare brand known for its luxurious offerings, is considering a comeback to the public market with a potential initial public offering in the US this year. This information comes from sources familiar with the company’s plans.
The brand is collaborating with investment giants JPMorgan Chase & Co. and Morgan Stanley to navigate through the intricacies of this prospective listing. However, the precise details remain under wraps as both L’Occitane and its banking partners have opted not to disclose any commentary.
Back in 2024, billionaire Reinold Geiger, alongside his team of investors, transitioned L’Occitane into a private entity, marking an end to its 14-year presence on the Hong Kong stock exchange. This pivotal move assigned the skincare titan a valuation of €6 billion ($7 billion) on an equity basis.
As discussions evolve, the specifics surrounding the IPO, including its timeline and execution, are still fluid. Potential investors keenly watch the situation as it could signal a significant shift in market strategy.
Tracing its roots back to 1976, L’Occitane was established by French entrepreneur Olivier Baussan, who began his journey by crafting essential oils from local botanicals like lavender in the scenic Provence region and offering them at nearby markets. The brand took a significant step by going public in Hong Kong in 2010, expanding its portfolio to eight renowned brands, including Elemis, Sol De Janeiro, and Melvita, and operating over 3,000 locations across 90 countries.
In its latest financial report, L’Occitane revealed an impressive sales figure of €2.8 billion for the financial year ending March 31, 2025. The Americas lead as its primary market, contributing 46 percent to overall sales, followed by Asia Pacific with nearly 30 percent, and the remaining income stream stemming from Europe, the Middle East, and Africa.
